TrialJournal of affective disorders2019

Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.

Jaimee L Heffner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.